Back
Climb Bio, Inc. 10K Form
Buy
56
CLYM
Climb Bio, Inc.
Last Price:
$4.88
Seasonality Move:
-22.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLYM News And Ratings
See the #1 stock for the next 7 days that we like better than CLYM
CLYM Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-12.2M |
| Price / Cash Flow: | 3451.99 |
| Annual Sales: | $2.60 |
| Price / Book: | 1.87 |
Profitability
| EPS (TTM): | -0.75080 |
|---|---|
| Net Income (TTM): | $-50.8M |
| Gross Margin: | $0 |
| Return on Equity: | -25.72% |
| Return on Assets: | -25.01% |
Climb Bio, Inc. Earnings Forecast
Key Climb Bio, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Climb Bio, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLYM |
| Website: | climbbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 18.38 |
| Quick Ratio: | 17.56 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLYM Technical Analysis vs Fundamental Analysis
Buy
56
Climb Bio, Inc. (CLYM)
is a Buy
Is Climb Bio, Inc. a Buy or a Sell?
-
Climb Bio, Inc. stock is rated a BuyThe current Climb Bio, Inc. [CLYM] share price is $4.85. The Score for CLYM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.